Total: 5 |
|
PMID (PMCID) | ||
---|---|---|
31105743 |
OTHER | |
Next-Generation Sequencing Analysis Reveals Novel Pathogenic Variants in Four Chinese Siblings With Late-Infantile Neuronal Ceroid Lipofuscinosis. | ||
Ren XT, Wang XH, Ding CH, Shen X, Zhang H, Zhang WH, Li JW, Ren CH, Fang F. Front Genet. 2019;10:370. |
||
We studied 4 late-infantile NCL siblings characterized by seizures, ataxia as early symptoms, followed by progressive regression in intelligence and behavior, but mutations are located in different genes. | ||
27343025 |
FEMALE | |
Chorea in Late-Infantile Neuronal Ceroid Lipofuscinosis: AnAtypical Presentation. | ||
Saini AG, Sankhyan N, Singhi P. Pediatr Neurol. 2016;60:75-8. |
||
Classic late-infantile neuronal ceroid lipofuscinosis is characterized by progressive intellectual and motor deterioration, seizures, vision loss, and early death. | ||
16759889 |
MIXED_SAMPLE | Child |
Novel CLN1 mutation in two Italian sibs with late infantile neuronal ceroid lipofuscinosis. | ||
Bonsignore M, Tessa A, Di Rosa G, Piemonte F, Dionisi-Vici C, Simonati A, Calamoneri F, Tortorella G, Santorelli FM. Eur J Paediatr Neurol. 2006;10(3):154-6. |
||
The clinical phenotype is that of a variant late-infantile neuronal ceroid lipofuscinosis and consisted of early-onset visual loss, psychomotor deterioration, and seizures. | ||
12728477 |
MALE | Child |
A case of late infantile neuronal ceroid lipofuscinosis. | ||
Lee CW, Bang H, Oh YG, Yun HS, Kim JD, Coe CJ. Yonsei Med J. 2003;44(2):331-5. |
||
We experienced a case of late infantile neuronal ceroid lipofuscinosis in a 6-year-old boy who had progressive myoclonic seizures, ataxia, rapid psychomotor deterioration and visual loss. | ||
11782333 |
FEMALE | |
Anesthetic management for a patient with Jansky-Bielschowsky disease. | ||
Yamada Y, Doi K, Sakura S, Saito Y. Can J Anaesth. 2002;49(1):81-3. |
||
To describe the anesthetic management of a patient with Jansky-Bielschowsky disease (JBD), the late infantile form of neuronal ceroid lipofuscinosis, characterized by dementia, severe and drug resistant grand mal, myoclonic seizures, and blindness. |